Revvity Net Profit Margin 2010-2024 | RVTY

Current and historical net profit margin for Revvity (RVTY) from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. Revvity net profit margin for the three months ending September 30, 2024 was .
Revvity Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-09-30 $2.72B $0.25B 9.33%
2024-06-30 $2.71B $0.17B 6.24%
2024-03-31 $2.73B $0.15B 5.50%
2023-12-31 $2.75B $0.69B 25.19%
2023-09-30 $2.80B $0.74B 26.54%
2023-06-30 $2.84B $0.82B 28.83%
2023-03-31 $3.02B $0.96B 31.78%
2022-12-31 $3.31B $0.57B 17.18%
2022-09-30 $3.00B $0.63B 21.03%
2022-06-30 $3.15B $0.67B 21.40%
2022-03-31 $3.48B $0.74B 21.28%
2021-12-31 $3.83B $0.94B 24.64%
2021-09-30 $3.63B $1.13B 31.19%
2021-06-30 $3.74B $1.18B 31.65%
2021-03-31 $3.32B $1.07B 32.33%
2020-12-31 $2.66B $0.73B 27.34%
2020-09-30 $3.23B $0.41B 12.77%
2020-06-30 $2.98B $0.30B 9.91%
2020-03-31 $2.89B $0.23B 7.86%
2019-12-31 $2.88B $0.23B 7.91%
2019-09-30 $2.84B $0.23B 8.25%
2019-06-30 $2.80B $0.25B 8.99%
2019-03-31 $2.78B $0.25B 8.88%
2018-12-31 $2.78B $0.24B 8.57%
2018-09-30 $2.66B $0.13B 4.73%
2018-06-30 $2.54B $0.14B 5.51%
2018-03-31 $2.39B $0.28B 11.73%
2017-12-31 $2.26B $0.29B 12.98%
2017-09-30 $2.18B $0.40B 18.29%
2017-06-30 $2.14B $0.37B 17.09%
2017-03-31 $2.13B $0.23B 10.61%
2016-12-31 $2.12B $0.23B 11.06%
2016-09-30 $2.00B $0.24B 11.86%
2016-06-30 $2.05B $0.23B 11.43%
2016-03-31 $2.08B $0.22B 10.55%
2015-12-31 $2.11B $0.21B 10.07%
2015-09-30 $2.10B $0.18B 8.35%
2015-06-30 $2.07B $0.16B 7.81%
2015-03-31 $2.07B $0.16B 7.89%
2014-12-31 $2.07B $0.16B 7.58%
2014-09-30 $2.22B $0.19B 8.70%
2014-06-30 $2.20B $0.19B 8.69%
2014-03-31 $2.18B $0.17B 7.74%
2013-12-31 $2.16B $0.17B 7.74%
2013-09-30 $2.13B $0.08B 3.94%
2013-06-30 $2.12B $0.07B 3.49%
2013-03-31 $2.10B $0.08B 3.81%
2012-12-31 $2.11B $0.07B 3.37%
2012-09-30 $2.08B $0.00B 0.14%
2012-06-30 $2.03B $0.01B 0.49%
2012-03-31 $1.98B $0.01B 0.30%
2011-12-31 $1.92B $0.01B 0.42%
2011-09-30 $1.85B $0.39B 21.02%
2011-06-30 $1.81B $0.36B 20.09%
2011-03-31 $1.76B $0.39B 22.34%
2010-12-31 $1.70B $0.39B 22.97%
2010-09-30 $1.54B $0.13B 8.53%
2010-06-30 $1.49B $0.13B 8.84%
2010-03-31 $1.51B $0.10B 6.36%
2009-12-31 $1.55B $0.08B 5.35%
Sector Industry Market Cap Revenue
Medical Medical Services $13.376B $2.751B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00